CMA have announced that the TGA may soon be conducting targeted listing compliance reviews on products containing Curcumin.

CMA have noted that the use of enhanced forms of curcumin and synergistic formulations in an attempt to address the issue of bioavailability make it difficult for consumers to compare one form of the ingredient against another and has resulted in a vast range of recommended daily dosages for similar indications and claims in the market, including claims over bioavailability and product potency.

If you require a review of your evidence or claims to ensure they are consistent with the current guidelines